Exploiting gene expression profiling to identify novel minimal residual disease markers of neuroblastoma Academic Article uri icon

Overview

MeSH Major

  • Gene Expression Profiling
  • Neoplasm, Residual
  • Neuroblastoma

abstract

  • Marker discovery based on differential gene expression profiling, stringent sensitivity and specificity assays, and well-annotated patient samples can rapidly prioritize and identify potential MRD markers of neuroblastoma.

publication date

  • November 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2670609

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-08-0541

PubMed ID

  • 18980998

Additional Document Info

start page

  • 7020

end page

  • 7

volume

  • 14

number

  • 21